Sinocelltech Group Limited (SHA:688520)

China flag China · Delayed Price · Currency is CNY
45.29
-0.18 (-0.40%)
Jan 22, 2026, 3:00 PM CST
23.37%
Market Cap20.25B
Revenue (ttm)1.89B
Net Income (ttm)-288.68M
Shares Out445.34M
EPS (ttm)-0.64
PE Ration/a
Forward PE84.20
Dividendn/a
Ex-Dividend Daten/a
Volume2,188,435
Average Volume3,322,196
Open45.53
Previous Close45.47
Day's Range44.90 - 46.12
52-Week Range34.61 - 89.04
Beta0.99
RSI41.26
Earnings DateApr 23, 2026

About Sinocelltech Group

Sinocelltech Group Limited, a biopharmaceutical company, engages in the research, development, and production of recombinant proteins, antibody drugs, and vaccines in China. The company offers Anjiayin, a third-generation recombinant coagulation factor VIII product for the treatment of hemophilia A; Anpingxi, an anti-CD20 monoclonal antibody for the treatment of CD20-positive diffuse large B-cell non-Hodgkin's lymphoma; Anjiarun, an adalimumab biosimilar for the treatment of various autoimmune diseases; Anbezu, a bevacizumab biosimilar for the ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 2,277
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688520
Full Company Profile

Financial Performance

Financial Statements